The Freedman laboratory at Dana-Farber Cancer Institute and Harvard Medical School studies how the noncoding genome contributes to cancer pathogenesis and progression. Our work is characterized by asking questions of biological and clinical significance and deploying the appropriate tools to rigorously test these hypotheses. We use a variety of molecular biology, statistical, genomic, and epigenomic approaches to understand cancer. If required, we develop novel technology. Our research is highly collaborative and includes laboratory investigators, clinical investigators, and computational biologists.

Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.

• PhD, MD or MD/PhD in biological sciences or equivalent
• Experience with epigenomic assays (e.g., ChIP-seq) and/or CRISPR-based screens.
• Strong work ethic, positive attitude, team-centered mentality and most importantly a passion for investigating novel areas.
• Outstanding interpersonal skills and excellent verbal and written communication skills.
• Background in molecular and/or cell biology, cancer biology and/or computational biology.
• Computational skills including computer programming are of interest but not mandatory

At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong.  As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff.  Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.

Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.

EEOC Poster